Avidity Partners Management LP 13D and 13G filings for Anika Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-02-11 6:54 pm Sale |
2021-12-31 | 13G | Anika Therapeutics, Inc. ANIK |
Avidity Partners Management LP | 0 0.000% |
-731,000![]() (Position Closed) |
Filing |
2021-02-16 12:01 pm Purchase |
2020-12-31 | 13G | Anika Therapeutics, Inc. ANIK |
Avidity Partners Management LP | 731,000 5.100% |
731,000![]() (New Position) |
Filing |